Acadia Pharma (ACAD) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $22.09 --0%
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
JFIN, KEQU, LASE, More
Revenue Growth %: +12.1%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q4 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
- Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
